Related Experiment Video
Updated: May 23, 2025
07:54
Use of a Hanging-weight System for Isolated Renal Artery Occlusion
Published on: July 19, 2011
15.9K
Limiting the gamble: Risk and predictability for renal replacement therapy in patients receiving mechanical
Kelsey Gore1, Dean Linder1, Juan José Martinez Duque2
1Department of Cardiovascular Perfusion and Extracorporeal Technology, Ochsner Health, 1514 Jefferson Highway, New Orleans, Louisiana 70121, USA.
The Journal of Extra-Corporeal Technology
|March 7, 2025
Summary
Patients on mechanical circulatory support (MCS) often need renal replacement therapy (RRT). Prior immunologic therapy or implanted devices like pacemakers/ICDs increase RRT risk in MCS patients.
Area of Science:
- Cardiology
- Nephrology
- Medical Technology
Background:
- Mechanical circulatory support (MCS) is frequently used in advanced heart failure.
- Patients on MCS often develop kidney dysfunction requiring renal replacement therapy (RRT).
- Identifying risk factors for RRT in MCS patients is crucial for improving outcomes.
Purpose of the Study:
- To investigate risk factors associated with the need for RRT in patients receiving MCS.
- To explore the relationship between patient characteristics, comorbidities, and RRT requirement.
Main Methods:
- A retrospective study of 129 patients who received MCS between January 2017 and October 2023.
- Machine learning analysis was employed to identify clinical variables linked to RRT.
- Statistical analysis included chi-squared tests and c-index calculation.
Main Results:
- The incidence of RRT in MCS patients was 36%.
- Prior immunologic therapy and the presence of pacemakers or internal cardiac defibrillators (ICDs) were significantly associated with RRT need (P=0.0003).
- Unfractionated heparin anticoagulation in these groups showed a higher RRT incidence (44%).
Conclusions:
- RRT incidence is high in patients requiring MCS.
- Prior immunologic therapy and implanted cardiac devices may indicate an elevated inflammatory state, increasing RRT risk.
- Alternative anticoagulation strategies beyond unfractionated heparin should be considered for MCS patients.
Related Concept Videos
01:17Factors Affecting Renal Clearance: Renal Impairment
47
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
47
01:27Dialysis
247
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
247
01:11Renal Failure: Dose Adjustments
54
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
54
01:22Heart Failure Drugs: Diuretics
318
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
318
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
360
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
360